Icon

Aricept ODT - (5,10 mg;TABLET, ORALLY DISINTEGRATING)

Donepezil hydrochloride EISAI INC
5,10 mg;TABLET, ORALLY DISINTEGRATING
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
Less Than 5
Less Than 5
Indicated for the treatment of dementia of the Alzheimer's type. Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer's disease.
Yes
****** ****** *** *** ***** ** **** **** ** **** ****** *******- *** ** **** *** *** ************ *********. ******* ***** *** ********** *** ******* **** ****** **** *********** *****. **** *** ****** ** ****** '***, ****** ******** *** *******. *** **** ***** **** *** ***** ******** *******.
Aricept ODT Patent 1
****** ****** *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** ****** *** \ *** *** *, **** ******* ******** ** *** **, ****
  1. ** ***, **** : ***** **** ****** ****** *** ****** ******** ************ **** ******* **** * *** ****** (***) ****.
  2. ***, **** : ***** ******* **** ****** ******

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.